The lean phenotype in metabolic dysfunction-associated steatotic liver disease: diagnostic challenges and prognostic implications: Correspondence to editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations”

Clinical and Molecular Hepatology 2026 Open access

Read full text

Authors: Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Dae Won Jun

DOI: 10.3350/cmh.2026.0143

Cited by: 1

References: 5

Abstract

List of abbreviations BMI = body mass index, MASLD = metabolic dysfunction-associated steatotic liver disease, NAFLD

Liver Disease Diagnosis and Treatment Diabetes Cardiovascular Risks and Lipoproteins Diabetes Treatment and Management

References 5